US 9657004
Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use
granted A61PA61P13/08A61P3/04
Quick answer
US patent 9657004 (Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use) held by Agios Pharmaceuticals, Inc. expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61P, A61P13/08, A61P3/04, A61P3/10, A61P35/00